IRLAB Therapeutics AB (publ)
SSE:IRLAB-A.ST
14.45 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 42.777 | 0 | -1.192 | 0 | 6.87 | 0 | 12.181 | 16.503 | 23.41 | 9.042 | 12.141 | 195.641 | 0 | 0 | 0 | -0.029 | 0.106 | 0.3 | -0.038 | -0.022 | 0.026 | 0 | 0.018 | 0 | 0.184 | 0 | 0.015 | 0.046 | 0.005 | 0.043 | -0.018 | 0.096 | 0.048 | 0.029 |
| Cost of Revenue
| 52.298 | 1.152 | 34.387 | 1.08 | 51.021 | 1.081 | 44.965 | 40.208 | 50.163 | 37.831 | 34.985 | 34.89 | 0.915 | 0.636 | 12.92 | 22.055 | 17.788 | 12.867 | 19.51 | 16.701 | 22.875 | 0 | 13.384 | 11.994 | 17.329 | 0 | 6.776 | 18.037 | 7.357 | 8.06 | 10.079 | 6.333 | 7.054 | 11.781 |
| Gross Profit
| -9.521 | -1.152 | -35.579 | -1.08 | -44.151 | -1.081 | -32.784 | -23.705 | -26.753 | -28.789 | -22.844 | 160.751 | -0.915 | -0.636 | -12.92 | -22.084 | -17.682 | -12.567 | -19.548 | -16.723 | -22.849 | 0 | -13.366 | -11.994 | -17.145 | 0 | -6.761 | -17.991 | -7.352 | -8.017 | -10.097 | -6.237 | -7.006 | -11.752 |
| Gross Profit Ratio
| -0.223 | 0 | 29.848 | 0 | -6.427 | 0 | -2.691 | -1.436 | -1.143 | -3.184 | -1.882 | 0.822 | 0 | 0 | 0 | 761.517 | -166.811 | -41.89 | 514.421 | 760.136 | -878.808 | 0 | -742.556 | 0 | -93.179 | 0 | -450.733 | -391.109 | -1,470.4 | -186.442 | 560.944 | -64.969 | -145.958 | -405.241 |
| Reseach & Development Expenses
| 49.073 | 28.937 | 29.654 | 34.974 | 44.915 | 41.769 | 36.797 | 33.64 | 44.498 | 31.243 | 29.78 | 39.091 | 22.046 | 16.454 | 16.436 | 21.058 | 22.514 | 15.981 | 22.025 | 18.861 | 25.265 | 13.23 | 14.215 | 13.132 | 18.818 | 12.762 | 10.582 | 18.686 | 8.993 | 6.958 | 9.305 | 8.68 | 10.667 | 10.312 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 38.737 | 37.129 | 30.431 | 28.801 | 39.461 | 27.213 | 24.389 | 26.046 | 18.084 | 13.219 | 12.92 | 22.055 | 17.788 | 12.867 | 19.509 | 16.701 | 22.875 | 12.075 | 13.385 | 11.993 | 17.329 | 11.563 | 9.148 | 18.037 | 7.357 | 8.06 | 12.339 | 6.333 | 7.054 | 11.781 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| -49.073 | 7.272 | 10.862 | 5.048 | 38.737 | 37.129 | 30.431 | 28.801 | 39.461 | 27.213 | 24.389 | 26.046 | 18.084 | 13.219 | 12.92 | 22.055 | 17.788 | 12.867 | 19.509 | 16.701 | 22.875 | 12.075 | 13.385 | 11.993 | 17.329 | 11.563 | 9.148 | 18.037 | 7.357 | 8.06 | 12.339 | 6.333 | 7.054 | 11.781 |
| Other Expenses
| -52.341 | 0 | 0 | 0 | 0 | 22.38 | 14.832 | 11.626 | 10.965 | 10.917 | 10.353 | 8.84 | 8.437 | 6.749 | 6.505 | 4.814 | 8.315 | 6.195 | 6.88 | 4.788 | 7.547 | 5.573 | 5.268 | 3.87 | 6.587 | 4.288 | 4.927 | 2.699 | 3.289 | 1.872 | 2.269 | 4.372 | -0.202 | 2.252 |
| Operating Expenses
| 47.879 | 36.209 | 34.457 | 40.738 | 51.742 | 59.509 | 45.263 | 40.427 | 50.426 | 38.13 | 34.742 | 34.886 | 26.521 | 19.968 | 19.425 | 26.869 | 26.103 | 19.062 | 26.389 | 21.489 | 30.422 | 17.648 | 18.653 | 15.863 | 23.916 | 15.851 | 14.075 | 20.736 | 10.646 | 9.932 | 14.608 | 10.705 | 6.852 | 14.033 |
| Operating Income
| -9.521 | -37.361 | -35.579 | -40.738 | -44.872 | -59.508 | -33.082 | -23.924 | -27.015 | -29.088 | -22.601 | 121.665 | -26.521 | -19.967 | -19.425 | -26.869 | -26.103 | -19.062 | -26.315 | -21.489 | -30.395 | -17.648 | -18.634 | -15.864 | -23.548 | -15.851 | -12.999 | -20.689 | -10.641 | -9.889 | -17.755 | -10.608 | -6.803 | -14.033 |
| Operating Income Ratio
| -0.223 | 0 | 29.848 | 0 | -6.532 | 0 | -2.716 | -1.45 | -1.154 | -3.217 | -1.862 | 0.622 | 0 | 0 | 0 | 926.517 | -246.255 | -63.54 | 692.5 | 976.773 | -1,169.038 | 0 | -1,035.222 | 0 | -127.978 | 0 | -866.6 | -449.761 | -2,128.2 | -229.977 | 986.389 | -110.5 | -141.729 | -483.897 |
| Total Other Income Expenses Net
| 2.464 | -1.658 | 0.594 | 2.345 | -0.033 | -0.048 | -0.083 | -0.033 | -0.1 | -0.082 | -0.515 | -0.098 | -0.108 | -0.074 | -0.041 | -0.046 | -0.051 | -0.056 | -0.061 | -0.066 | -0.072 | -0.075 | 0.018 | 0.058 | -0.277 | 0 | 0.001 | 0.002 | -0.004 | -2.005 | 3.146 | -0.002 | -0.005 | -0.017 |
| Income Before Tax
| -7.057 | -39.019 | -34.985 | -38.393 | -44.905 | -59.556 | -33.165 | -23.957 | -27.115 | -29.17 | -23.116 | 121.567 | -26.629 | -20.041 | -19.466 | -26.915 | -26.154 | -19.118 | -26.376 | -21.555 | -30.467 | -17.723 | -18.616 | -15.806 | -23.825 | -15.851 | -12.998 | -20.687 | -10.645 | -11.894 | -14.609 | -10.61 | -6.808 | -14.05 |
| Income Before Tax Ratio
| -0.165 | 0 | 29.35 | 0 | -6.536 | 0 | -2.723 | -1.452 | -1.158 | -3.226 | -1.904 | 0.621 | 0 | 0 | 0 | 928.103 | -246.736 | -63.727 | 694.105 | 979.773 | -1,171.808 | 0 | -1,034.222 | 0 | -129.484 | 0 | -866.533 | -449.717 | -2,129 | -276.605 | 811.611 | -110.521 | -141.833 | -484.483 |
| Income Tax Expense
| 0 | 1.109 | 1.026 | 2.372 | 0.004 | 0.048 | 0.083 | 0.033 | 0.1 | 0.082 | 0.515 | 0.098 | 0.108 | 0.074 | 0.041 | 0.046 | 0.051 | 0.056 | 0.061 | 0.066 | -0.001 | 0.075 | -0.018 | -0.115 | 0.277 | 0 | 0.001 | -0.006 | 0.004 | 2.005 | -0.001 | 0.002 | -0.292 | -3.089 |
| Net Income
| -7.057 | -39.019 | -34.985 | -38.393 | -44.905 | -59.604 | -33.248 | -23.99 | -27.215 | -29.252 | -23.116 | 121.567 | -26.629 | -20.041 | -19.466 | -26.915 | -26.154 | -19.118 | -26.376 | -21.555 | -30.466 | -17.723 | -18.616 | -15.806 | -23.825 | -15.851 | -12.999 | -20.687 | -10.645 | -11.894 | -14.609 | -10.61 | -6.516 | -10.961 |
| Net Income Ratio
| -0.165 | 0 | 29.35 | 0 | -6.536 | 0 | -2.729 | -1.454 | -1.163 | -3.235 | -1.904 | 0.621 | 0 | 0 | 0 | 928.103 | -246.736 | -63.727 | 694.105 | 979.773 | -1,171.769 | 0 | -1,034.222 | 0 | -129.484 | 0 | -866.6 | -449.717 | -2,129 | -276.605 | 811.611 | -110.521 | -135.75 | -377.966 |
| EPS
| -0.14 | -0.75 | -0.67 | -0.74 | -0.87 | -1.15 | -0.64 | -0.46 | -0.53 | -0.57 | -0.45 | 2.35 | -0.51 | -0.39 | -0.4 | -0.55 | -0.54 | -0.42 | -0.65 | -0.53 | -0.75 | -0.45 | -0.46 | -0.075 | -0.65 | -0.45 | -0.37 | -0.59 | -0.3 | -0.4 | -0.58 | -0.42 | -0.26 | -0.51 |
| EPS Diluted
| -0.14 | -0.75 | -0.67 | -0.74 | -0.87 | -1.15 | -0.64 | -0.46 | -0.53 | -0.57 | -0.45 | 2.35 | -0.51 | -0.39 | -0.4 | -0.55 | -0.54 | -0.42 | -0.64 | -0.52 | -0.74 | -0.45 | -0.45 | -0.075 | -0.63 | -0.45 | -0.36 | -0.58 | -0.3 | -0.39 | -0.57 | -0.41 | -0.25 | -0.5 |
| EBITDA
| -8.37 | -36.209 | -34.509 | -37.286 | -43.783 | -58.423 | -31.217 | -22.912 | -26.057 | -28.145 | -22.029 | 122.591 | -25.606 | -19.331 | -18.856 | -26.3 | -25.538 | -18.509 | -25.023 | -20.941 | -29.849 | -17.102 | -17.763 | -15.734 | -23.398 | -15.669 | -12.916 | -20.601 | -10.552 | -9.801 | -14.521 | -10.529 | -6.727 | -13.957 |
| EBITDA Ratio
| -0.196 | 0 | 28.951 | 0 | -6.373 | 0 | -2.563 | -1.388 | -1.113 | -3.113 | -1.814 | 0.627 | 0 | 0 | 0 | 906.897 | -240.925 | -61.697 | 658.5 | 951.864 | -1,148.038 | 0 | -986.833 | 0 | -127.163 | 0 | -861.067 | -447.848 | -2,110.4 | -227.93 | 806.722 | -109.677 | -140.146 | -481.276 |